03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Spiriva* : | |
Type | Medicine Non Marketed |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Boehringer Ingelheim |
Responsible Party | Boehringer Ingelheim Pharma KG for Boehringer Ingelheim International GmbH |
Origin | Germany |
Manufacturer | Boehringer Ingelheim Pharma GmbH & Co KG |
Origin | Germany |
ATC | R03BB04 |
Spiriva* :
Spiriva* :
Spiriva* :
Spiriva* :
Spiriva* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Anaphylactic reactions | Not known |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Atrial fibrillation | Uncommon |
Bronchospasm | Rare |
Cephalea | Uncommon |
Constipation | Uncommon |
Cough | Uncommon |
Dehydration | Not known |
Dental caries | Not known |
Dry mouth (Xerostomia) | Common |
Dry skin | Not known |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dysphagia | Rare |
Dysphonia | Uncommon |
Dysuria (Micturition painful) | Uncommon |
Epistaxis (Nasal bleeding) | Rare |
Gastrooesophageal reflux disease | Uncommon |
Gingivitis | Rare |
Glaucoma | Rare |
Glossitis | Rare |
Hypersensitivity | Rare |
Ileus paralytic | Rare |
Immediate hypersensitivity reaction | Rare |
Insomnia | Rare |
Intestinal obstruction | Rare |
Intraocular pressure increased | Rare |
Joint swelling | Not known |
Laryngitis | Rare |
Lightheadedness | Uncommon |
Nausea | Rare |
Oropharyngeal candidiasis | Uncommon |
Palpitations | Rare |
Pharyngitis | Uncommon |
Pruritus | Rare |
Sinusitis | Rare |
Skin Eruption | Uncommon |
Skin infection | Not known |
Skin ulcer | Not known |
Stomatitis | Rare |
Supraventricular tachycardia | Rare |
Tachycardia | Rare |
Urinary retention | Uncommon |
Urinary tract infection | Rare |
Urticaria | Rare |
Vision blurred | Uncommon |
Spiriva* :
NB : Products With Same Indication |
Different Units By MoH Code
Spiriva* MoH 2369 :
Form | Inhalation powder, hard capsule |
Package Size | Box of 30 |
Strength | 18µg |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 973475/02 |
Submission date | 01/01/2002 |
Registration Year | 2002 |
Archived Date | 2014 |
Price Comparison
● Country: | Iceland | |
● Package Size: | 30 | |
● Public Price: | 7837 ISK | ( 5,054,865.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 261,2333 ISK | ( 168,345.00 LBP ) |
● Pharmacy Price: | 4632 ISK | ( 2987640 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 30 | |
● Public Price: | 44.32 JOD | ( 5,549,794.72 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 1,4773 JOD | ( 125,221.00 LBP ) |
● Pharmacy Price: | 33.82 JOD | ( 4234974.22 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 20/11/2019 | |
● Type: | Medicine Non Marketed |
● Country: | Denmark | |
● Package Size: | 30 | |
● Public Price: | 288.45 DKK | ( 3,742,927.20 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 9,615 DKK | ( 116,784.00 LBP ) |
● Pharmacy Price: | 209.37 DKK | ( 2716785.12 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 30 | |
● Public Price: | 33.5 GBP | ( 3,807,241.50 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 1,1167 GBP | ( 113,649.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | 30 doses | |
● Public Price: | 396.4 NOK | ( 3,212,425.60 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 13,2133 NOK | ( 105,352.00 LBP ) |
● Pharmacy Price: | 282.47 NOK | ( 2289136.88 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 30 | |
● Public Price: | 49.75 EUR | ( 4,819,581.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 1,6583 EUR | ( 96,876.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 1 inhalador + 30 cápsulas | |
● Public Price: | 39.25 EUR | ( 3,802,383.00 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 1,3083 EUR | ( 96,876.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Authorised |
● Country: | The Netherlands | |
● Package Size: | 30 | |
● Public Price: | 54.14 EUR | ( 5,244,866.64 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 1,8047 EUR | ( 96,876.00 LBP ) |
● Pharmacy Price: | 47.14 EUR | ( 4566734.64 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 | |
● Type: | Medicine Authorised |
● Country: | Sweden | |
● Package Size: | 30 | |
● Public Price: | 339.99 SEK | ( 2,858,635.92 LBP ) |
● Pack size unit used: | 30 | |
● Cost/Unit: | 11,333 SEK | ( 92,488.00 LBP ) |
● Pharmacy Price: | 288.1 SEK | ( 2422344.8 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 30 dose |
● Exfactory Price: | 50.37 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File